BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Regains Compliance with Nasdaq Listing Rules
Dec 12, 2022
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced the receipt of formal notifications from the Nasdaq Stock Market that the company has regained Nasdaq compliance regarding minimum stockholders’ equity and minimum bid price. The company previously reported receipt of the respective non-compliance notifications on Sept. 30 and Nov. 2, 2022. According to the update, Nasdaq indicated that it has determined, based on BiondVax’s Form 6-K dated Nov. 30, 2022, reporting third-quarter financial results, that the company once again complies with Listing Rule 5550(b)(1) regarding minimum $2.5 million stockholders’ equity. In addition, Nasdaq confirmed that since the minimum bid price has now closed over $1.00 per share for the past ten trading days, the company once again complies with Listing Rule 5550(a)(2).
To view the full press release, visit https://ibn.fm/WaGkt
About BiondVax Pharmaceuticals Ltd.
BiondVax is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Since its inception, BiondVax has executed eight clinical trials including a seven-country, 12,400-participant phase 3 trial of its prior vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (“NanoAb”) pipeline. For more information, visit the company’s website at www.BiondVax.com.
NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Chili’s Margaritas Rimmed With Degreaser Burn 5 People in North Carolina
Three customers and two employees were burned on and around their mouths after a granulated substance was mistaken for sugar, a health official said.
Binance Lost Over $6 Billion in Crypto Hack. Here’s What to Know.
Hackers made off with around $6 billion in digital currency in what could be the biggest crypto heist in history. Binance said it will cover the losses.
How Binance’s $6.3 Billion Hack Went Down
A war room. A global conference call. A founder who live-posted about the largest crypto heist in history. Inside a frantic 24 hours at the world’s biggest crypto exchange.
Judge Tosses Trump’s $10 Billion Suit Against The Wall Street Journal
The defamation suit focused on an article about a birthday note to Jeffrey Epstein. It was the president’s second attempt to claim the publication had acted with actual malice.
The New Hot Job in Law Doesn’t Require a J.D.
Big law firms, legal tech vendors, and in-house legal departments at companies like Microsoft and Nvidia are all hiring legal engineers, a new position for lawyers with A.I. skills.
Pick Another Protein? Americans Still Want Beef, Despite the Price.
After chicken, consumers are buying more beef, while pork, turkey and soy products remain flat.
The U.S. Becomes a Global Hub for Horse Racing
More horses from overseas are competing in America’s marquee events, as the sport enjoys a renaissance.
Why Did So Many People File Early for Social Security Last Year?
Experts point to well-publicized turmoil at the government agency last year as a potential spark.
Strengthening party self-governance and integrity for economic growth
The 20th Central Committee of the Communist Party of China convened its fifth plenary session in Beijing from October 26 to 29, 2026, where it deliberated and adopted the Resolution of the Central Committee of the Communist Party of China on Certain Major Issues concerning Persevering with Full and Rigorous Party Self-Governance.
70 years on, why global buyers keep coming back to Canton Fair
70 years on, why global buyers keep coming back to Canton Fair
China's manufacturing PMI at 49.3, non-manufacturing PMI at 49.7
China's purchasing managers' index for the manufacturing sector came in at 49.3 in October, down 0.8 percentage points from the previous month, while the non-manufacturing PMI stood at 49.7, down 0.5 percentage points.
How One Country Became the Unlikely Crossroads of the Global A.I. Boom
In Malaysia, U.S. and Chinese tech giants are pouring billions into vast data centers, straining local resources and testing the limits of Washington’s restrictions on advanced chips.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.